DTC.CSE
Defence Therapeutics Inc

2
Loading...
Loading...
Defence Therapeutics, Inc. engages in the research and development of anti-body drug conjugates. It focuses on enhancing intracellular delivery of biological or biosimilar therapeutic drugs targeting cancer and infectious diseases. The company was founded by Simon Beaudoin and Sébastien Plouffe on July 18, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Defence Therapeutics Inc?
What is the 52-week high for Defence Therapeutics Inc?
What is the 52-week low for Defence Therapeutics Inc?
What is Defence Therapeutics Inc stock price today?
What was Defence Therapeutics Inc stock price yesterday?
What is the PE ratio of Defence Therapeutics Inc?
What is the Price-to-Book ratio of Defence Therapeutics Inc?
What is the 50-day moving average of Defence Therapeutics Inc?

Latest DTC.CSE News

View
No DTC.CSE news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.